Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer. Zhang Y, Tacheva-Grigorova SK, Sutton J, Melton Z, et al. Clin Cancer Res 2023 Jan 23:OF1-OF15. doi: 10.1158/1078-0432.CCR-22-2293.

Read + Share

Amedeo Smart

Independent Medical Education

Zhang Y, Tacheva-Grigorova SK, Sutton J, Melton Z, et al. Allogeneic CAR T Cells Targeting DLL3 Are Efficacious and Safe in Preclinical Models of Small Cell Lung Cancer. Clin Cancer Res 2023 Jan 23:OF1-OF15. doi: 10.1158/1078-0432.CCR-22-2293.
PMID: 36692420